{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:40:47Z","timestamp":1786984847638,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003646","name":"National Health Insurance Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.atherosclerosis.2026.120698","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:21:28Z","timestamp":1772925688000},"page":"120698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Metabolic dysfunction\u2013associated steatotic liver disease and incident coronary events with revascularization: A nationwide cohort study"],"prefix":"10.1016","volume":"415","author":[{"given":"Minhong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joungyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8048-6247","authenticated-orcid":false,"given":"Hee-Taik","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.120698_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Alon","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101643","article-title":"Cardiovascular morbidity and mortality related to non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"48","author":"Bisaccia","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib4","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Mahfood Haddad","year":"2017","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib6","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gutjnl-2023-331003","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.35772\/ghm.2021.01008","article-title":"Epidemiology of cardiovascular disease and its risk factors in Korea","volume":"3","author":"Kim","year":"2021","journal-title":"Glob Health Med"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4070\/kcj.2020.0424","article-title":"Thirty-six year trends in mortality from diseases of circulatory System in Korea","volume":"51","author":"Baek","year":"2021","journal-title":"Korean Circ J"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016640","article-title":"Cohort profile: the national health insurance service-national health screening cohort (NHIS-HEALS) in Korea","volume":"7","author":"Seong","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914651","article-title":"Fatty liver index (FLI) identifies not only individuals with liver steatosis but also at high cardiometabolic risk","volume":"24","author":"Carli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001682","article-title":"Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese","volume":"94","author":"Huang","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib16","article-title":"Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies","volume":"10","author":"Liao","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib17","article-title":"Comprehensive review of cardiovascular disease risk in nonalcoholic fatty liver disease","volume":"9","author":"Josloff","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102938","article-title":"Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: a systematic review and meta-analysis","volume":"18","author":"Abosheaishaa","year":"2024","journal-title":"Diabetes Metabol Syndr"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib19","doi-asserted-by":"crossref","first-page":"e02","DOI":"10.15420\/ecr.2023.19","article-title":"Management of cardiovascular risk in the non-alcoholic fatty liver disease setting","volume":"19","author":"Linero","year":"2024","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib20","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3390\/diagnostics14202305","article-title":"Visceral obesity and its association with severe coronary artery calcification in patients with metabolic dysfunction-associated steatotic liver disease","volume":"14","author":"Kang","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib24","doi-asserted-by":"crossref","DOI":"10.4330\/wjc.v17.i6.106147","article-title":"Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: a review of pathogenesis","volume":"17","author":"Bharaj","year":"2025","journal-title":"World J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000735","article-title":"Metabolic dysfunction-associated steatotic liver disease and the heart","volume":"82","author":"Driessen","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","article-title":"AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120557","article-title":"Fatty liver-index, systemic inflammation and cardiovascular mortality. Results from the LURIC study","volume":"411","author":"Wissel","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/MEG.0000000000002865","article-title":"Fatty liver index as an independent predictor of all-cause and disease-specific mortality","volume":"36","author":"Zhang","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib29","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s10620-021-06954-y","article-title":"Fatty liver index and development of cardiovascular disease: findings from the UK biobank","volume":"66","author":"Zou","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s12872-024-04252-9","article-title":"Association of liver dysfunction with outcomes after percutaneous coronary intervention \u2013 a systematic review and meta-analysis","volume":"24","author":"Caldonazo","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.amjcard.2018.04.026","article-title":"Results of a 10-Year experience in Korea using drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction (from the Korea acute myocardial infarction registry)","volume":"122","author":"Kim","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib32","article-title":"Contemporary status of acute myocardial infarction in Korean patients: korean registry of acute myocardial infarction for regional cardiocerebrovascular centers","volume":"10","author":"Kim","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.atherosclerosis.2026.120698_bib33","article-title":"Statin use and liver-related prognosis among patients with MASLD","volume":"7","author":"Yun","year":"2025","journal-title":"JHEP Rep"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502600064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502600064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:36:13Z","timestamp":1779251773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502600064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"alternative-id":["S002191502600064X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120698","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysfunction\u2013associated steatotic liver disease and incident coronary events with revascularization: A nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120698"}}